Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
121.64B
Market cap121.64B
Price-Earnings ratio
33.24
Price-Earnings ratio33.24
Dividend yield
0.79%
Dividend yield0.79%
Average volume
4.97M
Average volume4.97M
High today
$174.92
High today$174.92
Low today
$171.14
Low today$171.14
Open price
$173.68
Open price$173.68
Volume
2.99M
Volume2.99M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$160.93
52 Week low$160.93

Stock Snapshot

As of today, Danaher(DHR) shares are valued at $172.00. The company's market cap stands at 121.64B, with a P/E ratio of 33.24 and a dividend yield of 79.1%.

On 2026-05-25, Danaher(DHR) stock traded between a low of $171.14 and a high of $174.92. Shares are currently priced at $172.00, which is +0.5% above the low and -1.7% below the high.

The Danaher(DHR)'s current trading volume is 2.99M, compared to an average daily volume of 4.97M.

In the last year, Danaher(DHR) shares hit a 52-week high of $242.80 and a 52-week low of $160.93.

In the last year, Danaher(DHR) shares hit a 52-week high of $242.80 and a 52-week low of $160.93.

DHR News

Investing.com 1d
Masimo earnings in focus as Danaher deal nears close - Investing.com

...

Masimo earnings in focus as Danaher deal nears close - Investing.com
Simply Wall St 2d
Danaher Is Up 6.2% After Q1 Beat, Higher EPS Guidance and Biotech Momentum - What's Changed

In recent weeks, Danaher reported stronger-than-expected Q1 earnings, raised its full-year adjusted EPS guidance, and highlighted 7% core revenue growth in its...

Danaher Is Up 6.2% After Q1 Beat, Higher EPS Guidance and Biotech Momentum - What's Changed
Simply Wall St 6d
Assessing Danaher Valuation After A Steep Share Price Pullback

Advertisement Why Danaher (DHR) is Drawing Investor Attention Now Danaher (DHR) is back on investor radars after a period of weaker share performance, with th...

Assessing Danaher Valuation After A Steep Share Price Pullback

Analyst ratings

93%

of 27 ratings
Buy
92.6%
Hold
7.4%
Sell
0%

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.